• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    紅內期瘧疾疫苗的研究進展

    2011-08-15 00:44:39陳琳黃復生
    成都醫(yī)學院學報 2011年2期
    關鍵詞:陳琳第三軍醫(yī)大學教研室

    陳琳,黃復生

    (第三軍醫(yī)大學基礎部病原生物學教研室,重慶 400038)

    Background

    Malaria remains one of the global devastating infectious disease,and results in 300-500 million clinical cases and nearly one million deaths annually worldwide[1,2].There are five species of Plasmodium parasites transmitted to humans:P.falciparum,P.vivax,P.ovale,P.malariae and P.knowlesi.P.falciparum is associated with the great majority of morbidity and mortality in human parasite,whereas P.vivax causes considerable symptomatic disease.Malaria is a mosquito-borne disease,and the parasite's sporozoites(SPZ)invade blood vessels and are transported to the liver after bitten by infected Anopheles mosquitoes.Here they infect hepatocytes,replicate and form a liver stage(LS)that grows asymptomatically.The blood-stage of the lifecycle commences when merozoites are released from the individual hepatocyte and infect erythrocytes.Red blood cell invasion is thought to involve multi-step process that several proteins at the parasite and erythrocyte surface receptor-ligand interaction[3].Once inside the red blood cell,parasites are partially hidden from immune recognition because erythrocytes lack a nucleus and major histocompatibility complex molecules.The parasites express proteins on the surface of infected erythrocyte and exposed to the immune system.

    Human repeated exposure to malaria parasites can naturally acquire immune and predominantly target the blood-stage parasites[4,5].Humoral-and cell-mediated immune responses play crucial roles in protective immunity against malaria parasites.But the immune effector mechanisms and the correlates of protection are poorly understood.It is suggested by passive immunoglobulin-transfer studies that antibodies are crucial components in blood-stage protective immunity,which may play a role in preventing merozoites invasion,antibody-dependent cell-mediated cytotoxity and greater clearance of infected red blood cell[6].With the development of resistance of malaria parasites to drugs and resistance of mosquitoes to insecticides,a cheap,broadly protective malaria vaccine is urgently required.A high level of antigenic diversity,redundancy of parasite invasion pathways and mechanisms of immune evasion pose significant challenges for vaccine development.The purpose of this review is to focus on the development of blood-stage vaccines,the advantages and challenges of this approach,potential target antigens expressed in the blood-stage and future directions.

    1 Potential targets

    The greatest challenge for developing effective blood-stage vaccine is the antigen diversity and identification of potential targets[7,8].At present,Merozoite surface proteins,as initial attachment antigens,and whole blood-stage parasites are the most promising candidates in blood-stage vaccine.

    1.1 Merozoite surface protein 1(MSP1)

    MSP1 is GPI(glycosylphosphatidylinositol)anchored to the merozoite surface and a 200 kDa polymorphic protein which undergoes proteolytic processing into four fragments p83,p30,p38,and p42.MSP1-42 undergoes secondary processing into two fragments p19 and p33.MSP1,which is important for the invasion process of erythrocytes by merozoite,is considered a prime candidate antigen for a blood stage vaccine.Several lines of evidence indicated thatthe C-terminal region of MSP1(MSP1-19 and-42)demonstrated the high antigenicity,and the naturally acquired antibodies to the C-terminus can inhibit the erythrocyte invasion and MSP processing[9,10].Therefore,both MSP1-42 and MSP1-19 fragments are thought to be the most advanced candidates for MSP1 vaccine development.But anti-MSP1-42 sera demonstrated strain-specific protection for P.falciparum-Aotus challenge model,and a PhaseⅡb trial of MSP1-42 in Kenyan found no protective effect[11].Antigen diversity was thought to a be major reason of failure of the vaccine.The study of genetic diversity in coding regions of PvMSP1-42 showed that 19kDa fragment at amino acid level was highly conserved in Sri Lankan isolates,whereas 33kDa fragment demonstrated extensive genetic diversity[12].But the opposite pattern was observed in P.falciparum[13].These observations indicate that the immunological interference between epitopes of PvMSP1-19 and PvMSP1-33 may affect the protection of PvMSP1-42 vaccine and a vaccine based on PvMSP1-19 alone could be effective against P.vivax infections in Sri Lankan.However,the analysis of antibody responses to PfMSP1-19 variant forms suggested the presence of cross-reactive antibody responses and non-variant specific antibodies to PfMSP1-19 in I-ranian individual infected by P.falciparum.One variant of this antigen,especially Q/KNG/L,may be sufficient for developing a PfMSP1-19-based vaccine[14].A study by Woehlbier showed that antibody elicited by entire MSP molecule can efficiently inhibit parasite multiplication and RBC invasion.Moreover,anti-MSP-1D antibodies would provide cross-protection for FCB-1 strain,a representative of K1 prototype.This study may provide the possibility of developing a vaccine based on the fullsize MSP1[15].

    1.2 Merozoite surface protein 2

    Merozoite surface protein 2(MSP-2)is a highly polymorphic 45-53 kDa protein,which like MSP-1,is also GPI anchored to the merozoite surface.High IgG3 antibody titers to MSP2 suggested that the molecule might be involved in protective immunity against P.falciparum[16,17].The N-and C-terminal domains of two allelic families,3D7 and FC27,are highly conserved with a variable region composed of central repeat region.MSP-2 was an important component in Combination B,including full-length 3D7 MSP2,block 2,3 of MSP1 and ring-infected erythrocyte surface antigen(RESA)formulated with the Montanide ISA720[18].A phase I/IIb field trial involving 120 children living in an area of Papua New Guinea reported that parasite densities were significantly decreased(62%)in the vaccine recipients[19].Furthermore,the activity of MSP-2 subunit included in the vaccine couldn't pro-tect against MSP-2 allelic family(FC27),suggesting that the major component of protective effect in Combination B was MSP-2[20].T he success of Combination B makes it possible that MSP-2 may be the most promising candidate antigen.Inclusion of both allelic variant in MSP-based vaccine could give the higher protective efficacy.Flueck found that two MSP-2 long synthetic peptides(LSP),comprising the semi-conserved family-specific domain plus the C-terminal domain of the two allelic families,could yield high titer antibody responses,and the response was associated with protective effect[21].However,MSP-2 is an intrinsically unstructured protein,which contains a single intramolecular disulphide bond and lacks hydrophobic residues.The lack of the structure knowledge of MSP-2 is the major hurdle to presume that an MSP-2 fragment will be as effective as the fulllength protein to induce a high antibody response.

    1.3 Merozoite surface protein 3

    Merozoite surface protein 3(MSP-3)is associated with merozoite surface through the non-covalent linkages and has been suggested to be involved in erythrocyte binding,although its function is unknown[22].Structurally,the C-terminal domain containing leucine zipper sequence is entirely conserved,whereas N-terminal region comprised of three blocks of heptad repeats is relatively polymorphic,which define two allele classes termed 3D7 and K1[23].The naturally acquired MSP-specific IgG3 antibody has strong antiparasitic effect in P.falciparum infected children.The cytophilic antibodies inhibited intra-erythrocytic parasite growth in a monocyte-dependent manner[24].In ADCI assays,amino acid residues 194 to 257 in C-terminal domain have been shown to exert a strong inhibition activity against P.falciparum parasite growth.MSP-3,as a long synthetic peptide,underwent a Phase Ib clinical trial among Tanzanian children and Burkina Faso adult males.The result showed that the MSP3-LSP vaccine with two adjuvants,Montanide ISA and aluminium hydroxide,was safe and immunogenic even at low dose in a malaria-na?ve population.Further studies are to define the true protective effects through Phase II clinical trial[25,26].However,recent studies demonstrated that the N-terminal domain of PfMSP3 is significantly more immunogenic than the C-terminal region.Antibody responses to N-terminal domain were largely allele specific and no been found allele specific within each allele class.These data raise the possibility for development of any PfMSP3 N-terminal domain-based vaccine[27,28].

    1.4 Apical membrane antigen-1

    AMA1 is thought to play an essential role in erythrocyte invasion.However,it is highly polymorphic and allelic-specific antibodies are not cross-protective[29].AMA1-C1 contains sequences from the FVO and 3D7 allelic form,adjuvanted with alhydrogel,and has progressed though Phase I/II trial in Mali.But the antibody levels were not maintained.Adding CPG 7909 to the AMA1/Alhydrogel formulation can improve immunogenicity[30].A vaccine containing the FVO form with three different adjuvants,including Alhydrogel,Montanide ISA 720 and ASO2A,Phase I clinical trail is ongoing and the highest antibody response were induced by ASO2A formulations[31].

    1.5 P.falciparum erythrocyte membrane protein-1

    P.falciparum erythrocyte membrane protein-1(PfEMP1)family is expressed on the surface of infected erythrocytes.PfEMP1 is encoded by 60 or more var genes.And different var genes encode PfEMP1 variants with different antigenic properties[32].The extreme variability of this antigen is a challenge for the development of a highly effective vaccine.The success of a subunit vaccine depended on its ability to elicit cross-reactive responses to different variants.A specific variant of PfEMP1,VAR2CSA,is thought to mediate parasite sequestration in the placenta and less antigenically diverse than other PfEMP1 variants.T he antibody raised against VAR2CSA is cross-reactive with different placental-binding isolates,showing that the development of an effective vaccine based on the conversed epitopes of VAR2CSA is possible[33].

    2 Whole blood-stage parasites approach

    Owing to the success of radiation-attenuated sporozoite studies,the whole-parasite vaccine has regained attention.There is evidence that na?ve adult human volunteers infected with a low dose of live P.falciparum parastes can develop cell-mediated immune response and ultra-low doses of irradiated or CpG adjuvanted killed parasites can induce cellular immunity against both heterologous and homologous parasites in animal models[34,35].The whole-parasite vaccine is likely to involve a vast array antigens,thus reducing the impact of antigenic polymorphisms.More recently,study has suggested that crude extract from Pf whole-parasite could elicit parasite antigen-specific immune response via Toll-like receptor(T LR)9,by adjuvanted with the malaria heme-detoxification byproduct,hemozoin(HZ).A synthetic HZ could be used as an adjuvant to improve immunogenicity of whole-parasite vaccines[36].However,the safety and large-scale production of whole-parasite vaccine is an important challenge for the widespread use.

    3 Challenges and future directions

    There are many evidences supporting the development of a vaccine based on blood-stage parasite antigens.However,the recent two Phase II clinical trials show no protective efficacy in African children.One possible hurdle for development of the blood-stage vaccine is the difference in parasitespecific,immune and pathogenic responses to malaria parasites between mice and humans.Recently,efforts are also going toward"humanize"the mouse model that a valid approach to evaluate blood-stage vaccine,but further studies are needed to evaluate their relevance.However,the greatest challenge for blood-stage vaccine development is perhaps highly antigenic polymorphism.Multiple antigens or allelic forms are possible required in a single vaccine to overcome the challenge.More knowledge on identification of potential antigens as blood-stage vaccine candidate isneeded.Highthroughput serological screening of whole plasmodium proteomes might guide vaccine and diagnostic antigen discovery[37].

    4 Conclusion

    In this review,we have highlighted the development and challenge of leading blood-stage candidate vaccine.Many target antigens expressed on the surface of merozoites have been demonstrated that antibodies to these proteins can confer protection against homologous parasite challenge.However,so far,no recombinant protein has been proved sufficiently efficacious in human test.Effective blood-stage vaccines will almost certainly need to choose several different antigens or several allelic types to overcome antigenic diversity.Therefore,there is a strong need for identification of a multitude of new antigens from genomic and proteomic insights.Recently,efforts are also underway to reexamine whole blood-stage parasite vaccines.We remain optimistic about the development of bloodstage vaccines against malaria and a highly effective vaccine is possible.

    [1]Snow RW,Guerra CA,Noor AM,et al.The g lobal distribution of clinical episodes of Plasmodium falciparum malaria[J].Nature,2005,434(7030):214-217.

    [2]Guerra CA,Gikandi PW,T atem AJ,et al.The limits and intensity of Plasmodium falciparum transmission:implications for malaria control and elimination worldwide[J].PLoS Med,2008,5(2):38.

    [3]Gilson PR,Crabb BS.Morphology and kinetics of the three distinct phases of red blood cell invasion by Plasmodium falciparum merozoites[J].International Journal for Parasitology,2009,39(1):91-96.

    [4]Marsh K,Snow RW.Host-parasite interaction and morbidity in malaria endemic areas[J].Philosophical Transactions of the Royal Society of London Series B Biological Sciences,1997,352(1359):1385-1394.

    [5]Doolan DL,Dobano C,Baird JK.Acquired immunity to malaria[J].Clin Microbiol Rev,2009,22(1):13-36.

    [6]Langhorne J,Ndungu FM,Sponaas AM,et al.Immunity to malaria:more questions than answers[J].Nat Immunol,2008,9(7):725-732.

    [7]Volkman SK,Hartl DL,Wirth DF,et al.Ex cess polymorphisms in genes for membrane proteins in Plasmodium falciparum[J].Science,2002,298(5591):216-218.

    [8]Polley SD,Conway DJ.Strong diversifying selection on domains of the Plasmodium falciparum apical membrane antigen 1 gene[J].Genetics,2001,158(4):1505-1512.

    [9]John CC,O'Donnell RA,Sumba PO,et al.Evidence that invasion-inhibitory antibodies specific for the 19-kDa fragment of merozoite surface protein-1(MSP-1 19)can play a protective role against blood-stage Plasmodium falciparum infection in individuals in a malaria endemic area of Africa[J].J Immunol,2004,173(1):666-72.

    [10]O'Donnell RA,de Koning-Ward TF,Burt RA,et al.A ntibodies against merozoite surface protein(M SP)-19 are a major component of the invasion-inhibitory response in individuals immune to malaria[J].J.Ex p.Med,2001,193(12):1403-1412.

    [11]Ogutu BR,Apollo OJ,Mckinney D,et al.Blood stage malaria vaccine eliciting high antigen-specific antibody concentrations confers no protection to young children in Western Kenya[J].P LoS One,2009,4(3):4708.

    [12]Dias S,Longacre S,Escalante AA,et al.Genetic diversity and recombination at the C-terminal fragment of the merozoite surface protein-1 of Plasmodium vivax(PvMSP-1)in Sri Lanka[J].Infect Genet Evol,2011,11(1):145-156.

    [13]Pacheco MA,Poe AC,Collins WE,et al.A comparative study of the genetic diversity of the 42 kDa fragment of the merozoite surface protein-1 in Plasmodium falciparum and P.vivax[J].Infect.Genet.Evol,2007,7(2):180-187.

    [14]Zakeri S,Mehrizi AA,Zoghi S,et al.Non-variant specific antibody responses to the C-terminal region of merozoite surface protein-1 of Plasmodium falciparum(PfMSP-1(19))in Iranians ex posed to unstable malaria transmission[J].Malar J,2010,9(9):257-263.

    [15]Woehlbier U,Epp C,Kauth CW,et al.Analysis of Antibodies Directed against Merozoite Surface Protein 1 of the Human M alaria Parasite Plasmodium falciparum[J].Infec Immun,2006,74(2):1313-1322.

    [16]M etzger WG,Okenu DM,Cavanagh DR,et al.Serum IgG3 to the Plasmodium falciparum merozoite surface protein 2 is strongly associated with a reduced prospective risk of malaria[J].Parasite Immunol,2003,25(6):307-312.

    [17]Stanisic DI,Richards JS,McCallum FJ,et al.IgG subclassspecific responses against Plasmodium falciparum merozoite antigens are associated with control of parasitemia and protection from symptomatic illness[J].Infect Immun,2009,77(3):1165-1174.

    [18]Genton B,Al-Yaman F,Betuela I,et al.Safety and immunogenicity ofa three-componentblood-stage malaria vaccine(MSP1,MSP2,RESA)against Plasmodium falciparum in Papua New Guinean children[J].Vaccine,2003,22(1):30-41.

    [19]Genton B,Betuela I,Felger I,et al.A recombinant blood-stage malaria vaccine reduces Plasmodium falciparum density and exerts selective pressure on parasite populations in a phase 1-2b trial in Papua New Guinea[J].J Infect Dis,2002,185(6):820-827.

    [20]Fluck C,Schopflin S,Smith T,et al.Effect of the malaria vaccine Combination B on merozoite surface antigen 2 diversity[J].Infect Genet Evol,2007,7(1):44-51.

    [21]Flueck C,Frank G,Smith T,et al.Evaluation of two long synthetic merozoite surface protein 2 peptides as malaria vaccine candidates[J].Vaccine,2009,27(20):2653-2661.

    [22]Rodriguez LE,Curtidor H,Ocampo M,et al.Identifying Plasmodium falciparum merozoite surface antigen 3(MSP3)protein peptides that bind specifically to erythrocy tes and inhibit merozoite invasion[J].Protein Sci,2005,14(7):1778-1786.

    [23]Huber W,Felger I,Matile H,et al.Limited sequence polymo rphism in the Plasmodium falciparum merozoite surface protein 3[J].Mol Biochem Parasitol,1997,87(2):231-234.

    [24]Roussilhon C,Oeuvray C,Mǜller-Graf C,et al.Long-term clinical protection from falciparum malaria is strongly associated with IgG3 antibodies to merozoite surface protein 3[J].PLos M ed,2007,4(11):320.

    [25]Sirima SB,Nebie I,Ouedraogo A,et al.Safety and immunogenicity of the Plasmodium falciparum merozoite surface protein-3 long synthetic peptide(MSP3-LSP)malaria vaccine in healthy,semi-immune adult males in Burkina Faso,West Africa[J].Vaccine,2007,25(14):2723-2732.

    [26]Lusingu JP,et al.Satisfactory safety and immunogenicity of MSP3 malaria vaccine candidate in Tanzanian children aged 12-24 months[J].Malar J,2009,8(6):163-171.

    [27]Polley SD,Tetteh KK,Lloyd JM,et al.Plasmodium falciparum merozoite surface protein 3 is a target of allele-specific immunity and alleles are maintained by natural selection[J].J Infect Dis,2007,195(2):279-287.

    [28]Jordan SJ,Oliveira AL,Hernandez JN,et al.Malaria Immunoepidemiology in Low Transmission:Correlation of Infecting Genotype and Immune Response to Domains of Plasmodium falciparum M erozoite Surface Protein 3[J].Infect Immun,2011,79(5):2070-2078.

    [29]Cortes A,Mellombo M,Mueller I,et al.Geographical structure of diversity and differences between symptomatic and asymptomatic infections for Plasmodium falciparum vaccine candidate AM A1[J].Infect Immun,2003,71(3):1416-1426.

    [30]Sagara I,Ellis RD,Dicko A,et al.A randomized and controlled Phase 1 study of the safety and immunogenicity of the AMA1-C1/Alhydrogel+CPG 7909 vaccine for Plasmodium falciparum malaria in semi-immune Malian adults[J].Vaccine,2009,27(52):7292-7298.

    [31]Roestenberg M,Remarque E,de Jonge E,et al.Safety and immunogenicity of a recombinant Plasmodium falciparum AM A1 malaria vaccine adjuvanted with Alhydrogel,Montanide ISA 720 or AS02[J].PLoS One,2008,3(12):3960.

    [32]Scherf A,Lopez-Rubio JJ,Riviere L.Antigenic variation in Plasmodium falciparum[J].Annu Rev Microbiol,2008,62:445-470.

    [33]Elliott SR,Duffy MF,Byrne TJ,et al.Cross-reactive surface epitopes on chondroitin sulfate A-adherent Plasmodium falciparum-infected ery throcytes are associated with transcription of var2csa[J].Infect Immun,2005,73(5):2848-2856.

    [34]Pinzon-Charry,A.and Good,M.F.Malaria vaccines:the case for a wholeorganism approach[J].Expert Opin.Biol,2008,8(4):441-448.

    [35]Pombo DJ,Lawrence G,Hirunpetcharat C,et al.Immunity to malaria after administration of ultra-low doses of red cells infected with Plasmodium falciparum[J].Lancet,2002,360(9333):610-617.

    [36]Coban C,Igari Y,Yagi M,et al.Immunogenicity of wholeparasite vaccines against Plasmodium falciparum involves malarial hemozoin and host T LR9[J].Cell Host Microbe,2010,7(1):50-61.

    [37]Davies DH,Liang X,Hernandez JE,et al.Profiling the humoral immune response to infection by using proteome microarray s:high-throughput vaccine and diagnostic antigen discovery[J].Proc Natl Acad Sci U S A,2005,102(3):547-552.

    猜你喜歡
    陳琳第三軍醫(yī)大學教研室
    海軍軍醫(yī)大學生理學教研室
    The Effects of θ on Stability in the θ-Milstein Method for Stochastic Differential Equations
    陳琳作品《一口清茶,板栗飄香》
    大眾文藝(2022年16期)2022-09-07 03:07:44
    海軍軍醫(yī)大學神經生物學教研室
    海軍軍醫(yī)大學免疫學教研室
    沒有絕對的天分,也沒有絕對的天才——指揮家陳琳專訪
    紅十字 從這里起飛 第三軍醫(yī)大學2017年運動會剪影
    解放軍健康(2017年3期)2017-11-23 02:19:52
    喜鵲 “驚魂”
    光明所系 幸福相托
    ——走進第三軍醫(yī)大學大坪醫(yī)院眼科??漆t(yī)院
    趣聞
    分憂(2014年9期)2014-09-22 04:55:36
    男人舔女人的私密视频| 国产成人一区二区三区免费视频网站| 热99久久久久精品小说推荐| 亚洲性夜色夜夜综合| 天堂中文最新版在线下载| 欧美激情高清一区二区三区| 制服诱惑二区| 精品欧美一区二区三区在线| 人人妻人人添人人爽欧美一区卜| 色视频在线一区二区三区| 高潮久久久久久久久久久不卡| 脱女人内裤的视频| 丝袜美足系列| 999精品在线视频| 动漫黄色视频在线观看| 亚洲精品一区蜜桃| 高清视频免费观看一区二区| 视频区欧美日本亚洲| 亚洲国产精品一区二区三区在线| 丝袜人妻中文字幕| 一区二区av电影网| 高清av免费在线| 黄色毛片三级朝国网站| 亚洲色图综合在线观看| av不卡在线播放| 好男人电影高清在线观看| 日韩欧美一区视频在线观看| 久久精品人人爽人人爽视色| 精品国产一区二区三区久久久樱花| 性高湖久久久久久久久免费观看| 国产免费现黄频在线看| 亚洲国产看品久久| 免费少妇av软件| 五月天丁香电影| 午夜91福利影院| 精品久久久精品久久久| 女人爽到高潮嗷嗷叫在线视频| 中文字幕精品免费在线观看视频| 国产精品麻豆人妻色哟哟久久| 日韩视频一区二区在线观看| 老司机午夜福利在线观看视频 | 久久青草综合色| 亚洲精品中文字幕在线视频| 岛国毛片在线播放| 国产精品秋霞免费鲁丝片| 日日摸夜夜添夜夜添小说| 婷婷成人精品国产| 十八禁网站免费在线| 成年人黄色毛片网站| 丰满迷人的少妇在线观看| 精品少妇一区二区三区视频日本电影| 少妇被粗大的猛进出69影院| 制服诱惑二区| 啦啦啦视频在线资源免费观看| 悠悠久久av| 91精品三级在线观看| 欧美日韩视频精品一区| 丝袜美足系列| 国产xxxxx性猛交| 欧美xxⅹ黑人| 国产精品免费大片| 建设人人有责人人尽责人人享有的| 久热这里只有精品99| 欧美精品一区二区大全| svipshipincom国产片| 岛国在线观看网站| 18禁国产床啪视频网站| 美女主播在线视频| 亚洲成人手机| 啦啦啦免费观看视频1| 狠狠狠狠99中文字幕| 大码成人一级视频| 亚洲五月色婷婷综合| 国产精品久久久人人做人人爽| 中亚洲国语对白在线视频| 多毛熟女@视频| 亚洲专区国产一区二区| 高清视频免费观看一区二区| 日韩一卡2卡3卡4卡2021年| 99九九在线精品视频| videos熟女内射| 久久人妻福利社区极品人妻图片| 午夜久久久在线观看| 下体分泌物呈黄色| 少妇被粗大的猛进出69影院| 最黄视频免费看| 丁香六月欧美| 国产成人系列免费观看| 又大又爽又粗| 久久影院123| 欧美日韩黄片免| 国产在线免费精品| 国产成人欧美在线观看 | 亚洲精品久久午夜乱码| 亚洲伊人色综图| 99精国产麻豆久久婷婷| 少妇的丰满在线观看| 国产精品熟女久久久久浪| 精品国产一区二区三区四区第35| 国产成人影院久久av| 成人18禁高潮啪啪吃奶动态图| 热re99久久精品国产66热6| 在线精品无人区一区二区三| 操出白浆在线播放| 国产精品久久久久成人av| 国产xxxxx性猛交| 久久天躁狠狠躁夜夜2o2o| 久久久久精品国产欧美久久久 | 亚洲av日韩在线播放| 一级片'在线观看视频| 精品福利观看| 欧美日本中文国产一区发布| 久久这里只有精品19| 无限看片的www在线观看| 日本欧美视频一区| 亚洲精品日韩在线中文字幕| 国产成人免费无遮挡视频| 极品少妇高潮喷水抽搐| 又大又爽又粗| 窝窝影院91人妻| 午夜免费成人在线视频| 久久免费观看电影| 国产1区2区3区精品| 精品亚洲乱码少妇综合久久| 午夜福利在线观看吧| 黑人欧美特级aaaaaa片| 韩国精品一区二区三区| a级毛片在线看网站| 亚洲av电影在线观看一区二区三区| 欧美日韩黄片免| 一个人免费在线观看的高清视频 | 999久久久国产精品视频| 天天添夜夜摸| 正在播放国产对白刺激| 亚洲精品一区蜜桃| 黄片大片在线免费观看| 国产在视频线精品| a级片在线免费高清观看视频| 69精品国产乱码久久久| 久久久久网色| 国产一区二区三区综合在线观看| 精品欧美一区二区三区在线| 飞空精品影院首页| 精品福利永久在线观看| 啦啦啦在线免费观看视频4| 精品亚洲成a人片在线观看| 69av精品久久久久久 | 国产无遮挡羞羞视频在线观看| 久久久久精品人妻al黑| 国产成人免费观看mmmm| 黄网站色视频无遮挡免费观看| 国产精品九九99| 各种免费的搞黄视频| 精品福利观看| 捣出白浆h1v1| 午夜久久久在线观看| 国产无遮挡羞羞视频在线观看| 国产成人精品在线电影| 高清在线国产一区| 国产野战对白在线观看| 亚洲精华国产精华精| 一级毛片女人18水好多| 欧美97在线视频| 91国产中文字幕| 丝袜美足系列| 久久亚洲国产成人精品v| 久久久久精品人妻al黑| 欧美日韩一级在线毛片| 欧美人与性动交α欧美软件| 啦啦啦 在线观看视频| 国产成人欧美在线观看 | 亚洲一区中文字幕在线| 国产在线免费精品| 国产片内射在线| 成人av一区二区三区在线看 | 国产日韩欧美视频二区| 性色av乱码一区二区三区2| 成人影院久久| 国产一区有黄有色的免费视频| 亚洲精品日韩在线中文字幕| 老司机深夜福利视频在线观看 | 午夜日韩欧美国产| 欧美午夜高清在线| 狂野欧美激情性xxxx| 国产亚洲av高清不卡| 大香蕉久久网| 亚洲精品国产色婷婷电影| 亚洲精品中文字幕在线视频| 国产男女超爽视频在线观看| 又大又爽又粗| 久久久久国产一级毛片高清牌| 人妻久久中文字幕网| xxxhd国产人妻xxx| 欧美国产精品va在线观看不卡| 久久精品国产a三级三级三级| 亚洲av日韩在线播放| 精品国产乱子伦一区二区三区 | 高清在线国产一区| 欧美+亚洲+日韩+国产| av网站免费在线观看视频| 亚洲 欧美一区二区三区| 欧美av亚洲av综合av国产av| 99香蕉大伊视频| 五月天丁香电影| 亚洲精品美女久久av网站| 中文字幕色久视频| 悠悠久久av| 久久99一区二区三区| 日本av手机在线免费观看| 亚洲成人免费av在线播放| 免费高清在线观看视频在线观看| 超碰成人久久| 国产免费现黄频在线看| 色视频在线一区二区三区| 午夜影院在线不卡| 极品人妻少妇av视频| 又紧又爽又黄一区二区| 国产伦人伦偷精品视频| 久久 成人 亚洲| 日本欧美视频一区| 日本撒尿小便嘘嘘汇集6| 亚洲五月色婷婷综合| 国产av精品麻豆| 国产精品一区二区在线不卡| 美女中出高潮动态图| 国产欧美日韩综合在线一区二区| 又紧又爽又黄一区二区| 国产成人精品无人区| 久久青草综合色| 久久精品熟女亚洲av麻豆精品| 欧美人与性动交α欧美精品济南到| 美女国产高潮福利片在线看| 成人免费观看视频高清| 久久久久久久久免费视频了| 在线永久观看黄色视频| 成人三级做爰电影| 女人高潮潮喷娇喘18禁视频| 日本一区二区免费在线视频| 丰满饥渴人妻一区二区三| 肉色欧美久久久久久久蜜桃| 搡老乐熟女国产| 亚洲成人免费电影在线观看| 久热这里只有精品99| 精品免费久久久久久久清纯 | 亚洲精品成人av观看孕妇| 中文字幕制服av| 日韩熟女老妇一区二区性免费视频| 欧美亚洲 丝袜 人妻 在线| 午夜久久久在线观看| 九色亚洲精品在线播放| 久久精品国产亚洲av香蕉五月 | 日本五十路高清| 日韩欧美免费精品| 亚洲第一欧美日韩一区二区三区 | 国产免费视频播放在线视频| h视频一区二区三区| 日本wwww免费看| 建设人人有责人人尽责人人享有的| 免费女性裸体啪啪无遮挡网站| 久久99热这里只频精品6学生| 青春草视频在线免费观看| 国产国语露脸激情在线看| 久久人人爽人人片av| 丝袜美腿诱惑在线| 黑人操中国人逼视频| 99re6热这里在线精品视频| 2018国产大陆天天弄谢| 少妇精品久久久久久久| 日韩一卡2卡3卡4卡2021年| 欧美日韩黄片免| av超薄肉色丝袜交足视频| 亚洲欧美一区二区三区久久| 成人亚洲精品一区在线观看| 免费在线观看日本一区| 亚洲,欧美精品.| 亚洲国产欧美在线一区| 国产精品麻豆人妻色哟哟久久| 国产欧美日韩综合在线一区二区| 亚洲精品国产区一区二| 国产精品成人在线| 亚洲中文字幕日韩| a在线观看视频网站| 99国产精品一区二区三区| 性高湖久久久久久久久免费观看| 亚洲色图综合在线观看| 捣出白浆h1v1| xxxhd国产人妻xxx| 精品少妇黑人巨大在线播放| 9色porny在线观看| a级片在线免费高清观看视频| 国产亚洲欧美精品永久| 日韩 欧美 亚洲 中文字幕| 亚洲伊人久久精品综合| www.自偷自拍.com| 精品熟女少妇八av免费久了| 女人被躁到高潮嗷嗷叫费观| 一区在线观看完整版| 又紧又爽又黄一区二区| 1024视频免费在线观看| 日韩 亚洲 欧美在线| 国产有黄有色有爽视频| 天天躁日日躁夜夜躁夜夜| 精品人妻熟女毛片av久久网站| 男女国产视频网站| 国产精品国产av在线观看| 色综合欧美亚洲国产小说| 涩涩av久久男人的天堂| 99久久精品国产亚洲精品| 三上悠亚av全集在线观看| 中文欧美无线码| 一级黄色大片毛片| 亚洲精品日韩在线中文字幕| 亚洲五月色婷婷综合| 欧美在线一区亚洲| 97人妻天天添夜夜摸| 亚洲欧美一区二区三区黑人| 女人爽到高潮嗷嗷叫在线视频| 女性生殖器流出的白浆| 精品高清国产在线一区| 精品久久久久久久毛片微露脸 | 精品乱码久久久久久99久播| 十八禁网站网址无遮挡| 爱豆传媒免费全集在线观看| 亚洲伊人色综图| 18禁黄网站禁片午夜丰满| 不卡一级毛片| 国产一区二区三区av在线| 国产日韩欧美视频二区| 国产精品偷伦视频观看了| 亚洲精品第二区| 亚洲国产欧美一区二区综合| 欧美精品亚洲一区二区| 亚洲黑人精品在线| 国产精品久久久久久精品电影小说| 91av网站免费观看| 免费在线观看视频国产中文字幕亚洲 | 视频区图区小说| 12—13女人毛片做爰片一| 桃红色精品国产亚洲av| 动漫黄色视频在线观看| 一区在线观看完整版| 热re99久久精品国产66热6| 日韩大码丰满熟妇| 亚洲精品在线美女| 欧美人与性动交α欧美精品济南到| 啦啦啦啦在线视频资源| 制服诱惑二区| 纯流量卡能插随身wifi吗| 欧美日韩视频精品一区| 在线亚洲精品国产二区图片欧美| 精品国产乱码久久久久久小说| 日韩中文字幕欧美一区二区| 这个男人来自地球电影免费观看| 日韩 亚洲 欧美在线| 日本a在线网址| 99九九在线精品视频| 日韩,欧美,国产一区二区三区| 丰满迷人的少妇在线观看| 午夜免费观看性视频| 老司机午夜福利在线观看视频 | 黄网站色视频无遮挡免费观看| 99国产精品一区二区蜜桃av | 久久香蕉激情| 蜜桃国产av成人99| 香蕉国产在线看| 亚洲熟女毛片儿| 嫁个100分男人电影在线观看| 欧美成人午夜精品| 欧美精品人与动牲交sv欧美| 国产精品久久久久久精品电影小说| 少妇裸体淫交视频免费看高清 | 精品欧美一区二区三区在线| 国产精品麻豆人妻色哟哟久久| 国产麻豆69| 一级a爱视频在线免费观看| www.av在线官网国产| 在线观看免费午夜福利视频| 久久久久久久久免费视频了| 精品福利观看| 99国产精品免费福利视频| a级毛片在线看网站| 黑人欧美特级aaaaaa片| 在线观看人妻少妇| 免费高清在线观看视频在线观看| 又黄又粗又硬又大视频| 亚洲成av片中文字幕在线观看| 亚洲国产欧美在线一区| 女人被躁到高潮嗷嗷叫费观| 亚洲国产欧美一区二区综合| 大片免费播放器 马上看| 久久天堂一区二区三区四区| 99热网站在线观看| 另类精品久久| 99国产精品一区二区蜜桃av | 母亲3免费完整高清在线观看| 9191精品国产免费久久| 亚洲,欧美精品.| 首页视频小说图片口味搜索| 国产精品麻豆人妻色哟哟久久| 自拍欧美九色日韩亚洲蝌蚪91| 美女中出高潮动态图| 国产亚洲午夜精品一区二区久久| 国产伦理片在线播放av一区| 久久99热这里只频精品6学生| 国产精品九九99| 亚洲国产欧美网| 精品国产乱码久久久久久男人| 我要看黄色一级片免费的| 国产精品av久久久久免费| 色视频在线一区二区三区| 久久亚洲精品不卡| 国产成人一区二区三区免费视频网站| 国产高清videossex| 少妇精品久久久久久久| 最黄视频免费看| 亚洲国产精品成人久久小说| 黄片小视频在线播放| 日本vs欧美在线观看视频| 国产精品1区2区在线观看. | 国产xxxxx性猛交| 新久久久久国产一级毛片| 久久人妻福利社区极品人妻图片| 天堂8中文在线网| avwww免费| 亚洲欧美成人综合另类久久久| 一边摸一边做爽爽视频免费| 精品国产乱码久久久久久男人| 高潮久久久久久久久久久不卡| 精品视频人人做人人爽| 一区二区av电影网| 黄网站色视频无遮挡免费观看| 亚洲精品中文字幕一二三四区 | 亚洲情色 制服丝袜| 午夜影院在线不卡| 男人操女人黄网站| www日本在线高清视频| 国产免费现黄频在线看| 亚洲成国产人片在线观看| 亚洲欧美激情在线| 一级片免费观看大全| 老司机影院成人| av超薄肉色丝袜交足视频| 动漫黄色视频在线观看| 国产一区二区在线观看av| 纯流量卡能插随身wifi吗| 后天国语完整版免费观看| 国产无遮挡羞羞视频在线观看| 老汉色∧v一级毛片| 在线观看免费视频网站a站| 亚洲精品国产一区二区精华液| 国产亚洲精品第一综合不卡| 免费在线观看黄色视频的| 亚洲中文字幕日韩| 国产成人影院久久av| 亚洲熟女毛片儿| 久久精品亚洲av国产电影网| 在线观看www视频免费| 久久九九热精品免费| 亚洲欧美激情在线| 69av精品久久久久久 | 精品少妇内射三级| 国产欧美日韩精品亚洲av| 91大片在线观看| 成年动漫av网址| 国产成人免费观看mmmm| 纯流量卡能插随身wifi吗| a在线观看视频网站| 一区二区三区乱码不卡18| 亚洲第一欧美日韩一区二区三区 | 精品久久久精品久久久| 欧美激情极品国产一区二区三区| 中国国产av一级| 一区福利在线观看| 首页视频小说图片口味搜索| 欧美+亚洲+日韩+国产| 操出白浆在线播放| 欧美日韩亚洲高清精品| 成年人黄色毛片网站| 亚洲五月色婷婷综合| 精品国产一区二区三区久久久樱花| 亚洲欧美一区二区三区黑人| 黑人操中国人逼视频| 久久久国产精品麻豆| 午夜免费鲁丝| 十八禁网站网址无遮挡| av天堂久久9| 久久av网站| 国产片内射在线| 热99久久久久精品小说推荐| 免费在线观看黄色视频的| 女人被躁到高潮嗷嗷叫费观| 欧美成狂野欧美在线观看| 下体分泌物呈黄色| 免费观看人在逋| 亚洲av成人一区二区三| 十八禁网站免费在线| 欧美精品av麻豆av| h视频一区二区三区| 国产97色在线日韩免费| 99久久人妻综合| 99香蕉大伊视频| 美女视频免费永久观看网站| 超色免费av| 国产亚洲av高清不卡| 一级,二级,三级黄色视频| 曰老女人黄片| 久久人妻熟女aⅴ| 欧美乱码精品一区二区三区| 久久久国产精品麻豆| 啦啦啦中文免费视频观看日本| 19禁男女啪啪无遮挡网站| 在线观看免费高清a一片| 久久99一区二区三区| 美女视频免费永久观看网站| 欧美一级毛片孕妇| 十八禁网站网址无遮挡| 欧美 亚洲 国产 日韩一| 亚洲激情五月婷婷啪啪| 91字幕亚洲| 国产精品免费大片| 性高湖久久久久久久久免费观看| 水蜜桃什么品种好| 久久久精品国产亚洲av高清涩受| av欧美777| 免费一级毛片在线播放高清视频 | 久久久精品国产亚洲av高清涩受| av视频免费观看在线观看| 亚洲中文日韩欧美视频| 最近最新免费中文字幕在线| 老熟女久久久| 丰满人妻熟妇乱又伦精品不卡| 久久精品人人爽人人爽视色| 97人妻天天添夜夜摸| 视频区图区小说| 考比视频在线观看| 99九九在线精品视频| 汤姆久久久久久久影院中文字幕| 精品亚洲成a人片在线观看| 国产高清国产精品国产三级| 精品国产一区二区三区久久久樱花| 一边摸一边做爽爽视频免费| 久久久久久亚洲精品国产蜜桃av| 欧美黑人欧美精品刺激| 欧美精品啪啪一区二区三区 | a级毛片黄视频| 香蕉国产在线看| 巨乳人妻的诱惑在线观看| av国产精品久久久久影院| 天天操日日干夜夜撸| 三上悠亚av全集在线观看| 夫妻午夜视频| 大陆偷拍与自拍| 性色av一级| 自拍欧美九色日韩亚洲蝌蚪91| 久久久水蜜桃国产精品网| 曰老女人黄片| 亚洲国产av影院在线观看| 亚洲视频免费观看视频| 又黄又粗又硬又大视频| 久久香蕉激情| 两个人免费观看高清视频| 黑人操中国人逼视频| 亚洲五月婷婷丁香| 日本欧美视频一区| 在线观看免费高清a一片| 麻豆av在线久日| 国产野战对白在线观看| 高潮久久久久久久久久久不卡| 国产成人精品久久二区二区91| 999久久久国产精品视频| 精品一区在线观看国产| 中文字幕另类日韩欧美亚洲嫩草| 老司机靠b影院| www.精华液| 亚洲性夜色夜夜综合| 国产无遮挡羞羞视频在线观看| 大片电影免费在线观看免费| 午夜福利免费观看在线| 建设人人有责人人尽责人人享有的| 精品久久蜜臀av无| 欧美激情极品国产一区二区三区| 一级a爱视频在线免费观看| e午夜精品久久久久久久| 91精品三级在线观看| 午夜激情av网站| 国产成人免费观看mmmm| 精品人妻熟女毛片av久久网站| 精品福利观看| 精品熟女少妇八av免费久了| 波多野结衣av一区二区av| 欧美另类一区| 黄色视频,在线免费观看| 亚洲精品中文字幕在线视频| 亚洲成国产人片在线观看| 他把我摸到了高潮在线观看 | 亚洲专区中文字幕在线| 欧美大码av| 亚洲av日韩在线播放| 黑人巨大精品欧美一区二区蜜桃| 国产高清国产精品国产三级| 男女免费视频国产| 久久精品国产a三级三级三级| 91老司机精品| 电影成人av| 波多野结衣av一区二区av| 免费一级毛片在线播放高清视频 | 精品国内亚洲2022精品成人 | 十八禁网站网址无遮挡| 曰老女人黄片| 女人精品久久久久毛片| 日韩三级视频一区二区三区| 亚洲欧美日韩另类电影网站| 欧美一级毛片孕妇| 久久精品人人爽人人爽视色| 激情视频va一区二区三区|